For example, in a bladder transitional cell carcinoma patient with clonal mutations in B2M and TP53 and whole genome doubling (WGD), GRITIC inferred that the B2M mutation happened after the TP53 mutation and the WGD (Fig. 2C). This evidence concerns the gene B2M and bladder transitional cell carcinoma.